Hydroxychloroquine
CAS: 118-42-3
Ref. 3D-FH40599
1mg | Descatalogado | ||
2mg | Descatalogado | ||
5mg | Descatalogado | ||
10mg | Descatalogado | ||
25mg | Descatalogado |
Información del producto
- (.+-.)-Hydroxychloroquine
- 2-([4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino)ethan-1-ol
- 2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol
- 7-Chloro-4-[4'-[ethyl (2''-hydroxyethyl) amino]-1'-methylbutylamino]quinoline
- 7-Chloro-4-[4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino]quinoline
- 7-Chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
- Ethanol, 2-[[4-[(7-chloro-4-quinolyl)amino]pentyl]ethylamino]-
- Hidroxicloroquina
- Hydroxychlorochin
- Oxichloroquine
- Ver más sinónimos
- Oxychlorochin
- Oxychloroquine
- Racemic Hydroxychloroquine
- Win 1258
- Win 1258-2
- Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-
Hydroxychloroquine is a 4-aminoquinolone that is used to prevent and treat malaria, caused by parasitic protozoan from the Plasmodium genus. Hydroxychloroquine is also used to treat non-infectious diseases such as rheumatoid arthritis and lupus thanks to its immunomodulatory properties. Recent studies revealed that hydroxychloroquine has beneficial effects on COVID-19 patients, as the current evidence shows that hydroxychloroquine inhibits SARS CoV-2 entry in host cells by interfering with endocytosis and affecting the glycoprofile on the spike glycoprotein.